Danggui Shaoyao San ameliorates Alzheimer’s disease by regulating lipid metabolism and inhibiting neuronal ferroptosis through the AMPK/Sp1/ACSL4 signaling pathway. This evidence concerns the gene PRKAA2 and early-onset autosomal dominant Alzheimer disease.